MIT Technology Review November 13, 2024
Jean-Philippe Vert, PhD

Embracing the paradigm shift of agentic AI could lead to massive advancements in healthcare as we know it.

The complexity of biology has long been a double-edged sword for scientific and medical progress. On one hand, the intricacy of systems (like the human immune response) offers countless opportunities for breakthroughs in medicine and healthcare. On the other hand, that very complexity has often stymied researchers, leaving some of the most significant medical challenges—like cancer or autoimmune diseases—without clear solutions.

The field needs a way to decipher this incredible complexity. Could the rise of agentic AI, artificial intelligence capable of autonomous decision-making and action, be the key to breaking through this impasse?

Agentic AI is not just another tool in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
NIH's unfinished business
Lilly blames slower-than-expected growth for 2024 sales miss
AbbVie to write off $3.5B over failed schizophrenia drug

Share This Article